Results 171 to 180 of about 2,697,911 (252)

Basic and clinical characteristics of diabetic β-thalassemia patients.

Basic and clinical characteristics of diabetic β-thalassemia patients.
Aily Aliasgharian (17781495), Hossein Karami (10119113), Amir Mosanejad-Galchali (17781492), Mehrnoush Kosaryan (17781489), Mohammad Naderisorki (11395283), Hasan Karami (17781498), Hadi Darvishi-Khezri (10119110), Mobin Ghazaiean (14440743)   +7 more
core   +1 more source

Application of third-generation sequencing technology in the genetic testing of thalassemia

Molecular Cytogenetics
Thalassemia is an autosomal recessive genetic disorder and a common form of Hemoglobinopathy. It is classified into α-thalassemia and β-thalassemia. This disease is mainly prevalent in tropical and subtropical regions, including southern China.
Weihao Li, Yanchou Ye
doaj   +1 more source

Gene Therapy in Patients with Transfusion‐Dependent β‐Thalassemia

New England Journal of Medicine, 2018
A. Thompson, M. Walters, J. Kwiatkowski, J. Rasko, J. Ribeil, S. Hongeng, E. Magrin, G. Schiller, E. Payen, M. Semeraro, D. Moshous, F. Lefrère, H. Puy, P. Bourget, A. Magnani, L. Caccavelli, J. Diana, F. Suarez, F. Monpoux, V. Brousse, C. Poirot, C. Brouzes, J. Meritet, C. Pondarré, Y. Beuzard, S. Chrétien, T. Lefèbvre, D. Teachey, U. Anurathapan, J. Ho, C. von Kalle, M. Kletzel, E. Vichinsky, S. Soni, G. Veres, O. Nègre, R. W. Ross, D. Davidson, Alexandria Petrusich, L. Sandler, M. Asmal, O. Hermine, M. de Montalembert, S. Hacein-Bey-Abina, S. Blanche, P. Leboulch, M. Cavazzana   +46 more
semanticscholar   +1 more source

Screening for (-(SEA)) α-globin gene deletion in β-thalassemia carriers and prevention of hydrops fetalis

, 2000
In Southeast Asia, where thalassemia is prevalent, heterozygous carriers of both β-thalassemia mutation and the (-(SEA)) α-globin gene deletion are encountered.
Ma, ESK, Chan, GCF, Yu Lung Lau, Shau Yin Ha, Li Chong Chan, Chan, AYY   +5 more
core  

Genetic Heterogeneity of β-thalassemia Variants in Affected Filipinos. [PDF]

Acta Med Philipp
Silao CLT, Manuel MCC, Davila RAE, Fabella TDF, Laude RP, Desengaño TGH, Estrada CAS, Barnuevo MM, Poblete JMS, Padilla CD, Naranjo MLT, Yuson ED.   +11 more
europepmc   +1 more source

Multisystem Complications in Non-Transfusion-Dependent β-Thalassemia Intermedia: A Case Highlighting the Need for Early Intervention. [PDF]

Clin Case Rep
Aloosh O, Hosseini SE, Karimi M.
europepmc   +1 more source

Use of romosozumab for osteoporosis in β-thalassemia major. [PDF]

JBMR Plus
Ng C, Samad N, Trinh A, Milat F, Wong P.
europepmc   +1 more source

New Gene Therapy Strategy for β-Thalassemia. [PDF]

Stem Cell Rev Rep
Liang D, Schmidt-Wolf IGH, Pu J.
europepmc   +1 more source

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study. [PDF]

Hemasphere
Benoit A, Pages J, Szepetowski S, Agouti I, Thuret I, Le Roux E, Badens C, Brousse V, NaThalY Network, Mathey C, Bey L, Lucchini MJ, Li Thio Te V, Garidi R, Garcon L, Orvain C, Brasme JF, Reynes C, Belloy M, Durin J, Alhindy O, Sabbagh L, Slama B, Sanchez A, Moulin A, Belgodere D, Benjemia L, Simon P, Oziol E, Aladjidi N, Huguenin Y, Jubert C, Forcade E, Duffau P, Maakaroun A, Lachenal F, Pegon C, Odievre MH, Petitdidier C, Atmani S, Raqbi F, Pondarre C, Youn J, Kamdem A, Bachir D, Bartolucci P, De Luna G, Habibi A, Fois E, Leblanc A, Dides PY, Makowski C, Armari C, Elenga N, Chantalat-Auger C, Driss F, Zenchri F, Guitton C, Jehanne M, Stoven C, Chaminade A, Gourdon S, Reguerre Y, Randriamalala E, Paumier-Bonjour V, Besancon-Bergelin A, Lambilliotte A, Bruno B, Gonzales F, Barbati M, Carpentier B, Piguet C, Touati M, Hot A, Barraco F, Cannas G, Virot E, Fort R, Ducoux G, Clavel HD, Kebaili K, Garnier N, Renard C, Bertrand Y, Peugnet AL, Halfon-Domenech C, Diakiesse J, Agbo-Kpati KP, Ravet N, Thuret I, Szepetowski S, Jean E, De Sainte Marie B, Meunier B, Faucher B, Muszlak M, Chamouine A, Garou A, Masserot-Lureau C, Schneider JM, Dorvaux V, Carassou P, Andriamihaja H, Lalande M, Mahe P, Sirvent A, Martinez PA, Bertchansky I, Eisenmann JC, Masseau A, Couec ML, Rialland F, Rohrlich PS, Baron-Joly S, Conde M, Dossier A, Brousse V, Yakouben K, Benkerrou M, Ithier G, Missud F, Dalle JH, Koehl B, Holvoet L, Ribeil JA, Joseph L, Cavazzana M, De Montalembert M, Neven B, Moshous D, Taylor M, Allali S, Varet B, Socie G, Xhaard A, De La Tour RP, Leblanc T, Boissel N, Robin M, Dhedin N, Girot R, Mattioni S, Lionnet F, Donadieu J, Leverger G, Fasola S, Arlet JB, Manoli C, Etienne-Julan M, Bernit E, Gellen-Dautremer J, Eyssette S, Blondin G, Pluchart C, Nimubona S, Bonneau J, Bayart S, Pertuisel S, Collet B, Detourmignies L, Machin J, Wemeau M, De Tourmigni L, Vannier JP, Filhon B, Dumesnil C, Lahary A, Schneider P, Ngo S, Malric A, Schoeny M, Berger C, Guichard I, Desbree A, Stephan JL, David A, Paillard C, Salmon A, Ame S, Gestas P, Besnard M, Castex MP, Plat-Wilson G, Cougoul P, Pasquet M, Serre J, Yvert M, Valentin JB, Duchene F, Mathieu S, Drouilly M, Detrait M, Pochon C, Phulpin A, Nathanson S.   +194 more
europepmc   +1 more source

Serum β2-microglobulin as a marker of renal tubular damage in transfusion-dependent β-thalassemia. [PDF]

Caspian J Intern Med
Akbari R, Mahmoodi Nesheli H, Salehi S, Hajiahmadi M, Sadr Moharerpour S.   +4 more
europepmc   +1 more source